“A near 2x~ improvement in the most important metrics doing something that is entirely risk-free and cost-free.”
Patients infused before 3pm kept their cancer controlled for 11.3 months versus 5.7. Median survival went from 16.4 months to 23.2. It costs nothing and standard care ignores it. The trial is a conference presentation without a peer-reviewed paper, and its registry entry changed several times.